| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Lineage Cell Therapeutics, Inc. | Director | Common Shares, no par value | 10K | $10.9K | $1.09 | Dec 29, 2023 | Direct |
| Lineage Cell Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 75K | Jul 1, 2024 | Direct | ||
| Jaguar Health, Inc. | Director | Stock option (right to buy) | 21K | Oct 8, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| JAGX | Jaguar Health, Inc. | Oct 8, 2024 | 1 | $0 | 4 | Oct 10, 2024 | Director |
| LCTX | Lineage Cell Therapeutics, Inc. | Jul 1, 2024 | 1 | $0 | 4 | Jul 3, 2024 | Director |
| LCTX | Lineage Cell Therapeutics, Inc. | Dec 29, 2023 | 1 | $10.9K | 4 | Jan 2, 2024 | Director |
| JAGX | Jaguar Health, Inc. | Jul 1, 2023 | 3 | $0 | 4 | Aug 14, 2023 | Director |
| LCTX | Lineage Cell Therapeutics, Inc. | Jul 1, 2023 | 1 | $0 | 4 | Jul 3, 2023 | Director |
| JAGX | Jaguar Health, Inc. | Apr 6, 2023 | 1 | $0 | 4 | Apr 6, 2023 | Director |
| LCTX | Lineage Cell Therapeutics, Inc. | Jul 1, 2022 | 1 | $0 | 4 | Jul 6, 2022 | Director |
| JAGX | Jaguar Health, Inc. | Jul 1, 2022 | 0 | $0 | 3 | Jul 5, 2022 | Director |
| LCTX | Lineage Cell Therapeutics, Inc. | Jul 1, 2021 | 1 | $0 | 4 | Jul 1, 2021 | Director |